Publication | Open Access

Antitumor effect of FGFR inhibitors on a novel cholangiocarcinoma patient derived xenograft mouse model endogenously expressing an FGFR2-CCDC6 fusion protein

Fgfr2-ccdc6 Fusion ProteinFgfr InhibitorsXenograft Mouse ModelMedicineBiliary CancerPathologyCancer BiologyTumor TargetingOncologyCell BiologyCancer ResearchTumor BiologyCancer Growth